Literature DB >> 2649689

Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

M Y Kuo1, M Chao, J Taylor.   

Abstract

Beginning with three partial cDNA clones of the RNA genome of human hepatitis delta virus (HDV), we assembled the complete 1,679-base sequence on a single molecule and then inserted a trimer of this into plasmid pSLV, a simian virus 40-based eucaryotic expression vector. This construct was used to transfect both monkey kidney (COS7) and human hepatocellular carcinoma (HuH7) cell lines. In this way we obtained replication of the HDV RNA genome and the appearance, in the nucleoli, of the delta antigen, the only known virus-coded protein. This proved both that the HDV genome could replicate in nonliver as well as liver cells and that there was no requirement for the presence of hepatitis B virus sequences or proteins. When the pSVL construct was made with a dimer of an HDV sequence with a 2-base-pair deletion in the open reading frame, genome replication was reduced at least 40-fold. However, when we cotransfected with a plasmid that expressed the correct delta antigen, the mutated dimer achieved a level of genome replication comparable to that of the nonmutated sequence. We thus conclude that the delta antigen can act in trans and is essential for replication of the HDV genome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649689      PMCID: PMC250607     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Preparation of a semipermanent mounting medium for fluorescent antibody studies.

Authors:  J RODRIGUEZ; F DEINHARDT
Journal:  Virology       Date:  1960-10       Impact factor: 3.616

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

4.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

5.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

Authors:  J H Ou; O Laub; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Delta hepatitis agent: structural and antigenic properties of the delta-associated particle.

Authors:  F Bonino; B Hoyer; J W Shih; M Rizzetto; R H Purcell; J L Gerin
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

8.  Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.

Authors:  A Ponzetto; P J Cote; H Popper; B H Hoyer; W T London; E C Ford; F Bonino; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  delta Antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection.

Authors:  E Stöcklin; F Gudat; G Krey; U Dürmüller; M Gasser; M Schmid; G Stalder; L Bianchi
Journal:  Hepatology       Date:  1981 May-Jun       Impact factor: 17.425

10.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.

Authors:  M Rizzetto; B Hoyer; M G Canese; J W Shih; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  199 in total

1.  Characterization of the 5' ends for polyadenylated RNAs synthesized during the replication of hepatitis delta virus.

Authors:  S Gudima; K Dingle; T T Wu; G Moraleda; J Taylor
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Unique properties of the large antigen of hepatitis delta virus.

Authors:  G Moraleda; S Seeholzer; V Bichko; R Dunbrack; J Otto; J Taylor
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Interactions between hepatitis delta virus proteins.

Authors:  G Moraleda; K Dingle; P Biswas; J Chang; H Zuccola; J Hogle; J Taylor
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 4.  The making of infectious viral RNA: No size limit in sight.

Authors:  M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  Specific HDV RNA-templated transcription by pol II in vitro.

Authors:  J Filipovska; M M Konarska
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

6.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 8.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

9.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Determination of the multimerization state of the hepatitis delta virus antigens in vivo.

Authors:  Cromwell T Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.